Nonrheumatic pulmonary valve disorders
ICD-10 I37 is a used to indicate a diagnosis of nonrheumatic pulmonary valve disorders.
Nonrheumatic pulmonary valve disorders encompass a range of conditions affecting the pulmonary valve, which is responsible for regulating blood flow from the right ventricle to the pulmonary artery. These disorders can include pulmonary valve stenosis, regurgitation, and atresia, often resulting from congenital defects or degenerative changes. Clinically, patients may present with symptoms such as dyspnea, fatigue, and syncope, particularly during exertion. The anatomy involved includes the right ventricle, pulmonary valve, and pulmonary artery, with dysfunction potentially leading to right ventricular hypertrophy and heart failure over time. Disease progression can vary, with some patients remaining asymptomatic for years, while others may experience rapid deterioration necessitating surgical intervention. Diagnostic considerations include echocardiography, which is essential for assessing valve morphology and function, as well as cardiac MRI or CT for detailed anatomical evaluation. Holter monitoring may also be indicated to assess for arrhythmias associated with valve disorders.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I37 covers nonrheumatic pulmonary valve disorders, including pulmonary valve stenosis, regurgitation, and atresia. These conditions can arise from congenital anomalies or degenerative changes and are diagnosed based on clinical symptoms and imaging studies.
I37 should be used when the pulmonary valve disorder is confirmed to be nonrheumatic in nature. If the disorder is due to rheumatic heart disease, codes from the I34 series should be utilized instead.
Documentation should include clinical findings, imaging results (such as echocardiograms), and any relevant history of congenital heart disease or previous interventions. Detailed notes on symptoms and functional status are also essential.
